CTRI/2024/03/064586尚未招募3 期
pfront Surgery Vs Induction Chemotherapy Followed By Surgery In Oral Cavity Squamous Cell Cancers With Advanced Nodal Disease (SurVIC Trial): A Phase 3 Multicentric Randomized Controlled Trial - SurVIC Trial
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Biopsy proven, operable oral Squamous cell carcinoma cT1-T4; cN2-N3, with adequate organ function, Age- 18-75 years, ECOG-PS:0-2
排除标准
- •Pregnant, History of moderate to severe hearing loss, History of previous malignancy excluding non-melanoma skin cancers or cervical carcinoma in situ, Documented Weight loss of more than 15% in the last 6 months, or Patients with known HIV, hepatitis B or C infection.
研究者
相似试验
招募中
3 期
Cancer injection before surgery vs after surgery in stomach cancerCTRI/2021/01/030183Jawaharlal Institute of Postgraduate Medical Education and Reserach
进行中（未招募）
1 期
Chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastasesThe CHARISMA randomized multicenter clinical trialEUCTR2013-004952-39-NLErasmus MC Cancer Institute224
已完成
3 期
eo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases ;The CHARISMA randomized multicenter clinical trialLiver metastases colorectal cancer1001981510017998NL-OMON44796Erasmus MC, Universitair Medisch Centrum Rotterdam224
尚未招募
不适用
Chemotherapy followed by versus surgery alone in high-risk patients with colorectal liver metastasesColorectal liver metastases, clinical risk score, high risk patients, colorectale levermetastasen, klinische risico score, hoog risico patientenNL-OMON27498Prof. Dr. C. VerhoefErasmus MC Cancer Institute224
尚未招募
3 期
Surgery first vs chemotherapy first in early triple negative and HER2 positive breast cancer.CTRI/2024/02/063118Tata Memorial Centre